
Although regional differences in provider recommendation of human papillomavirus (HPV) vaccine have been documented, limited research has examined variation at the state level. Therefore, this study examined state-level differences in caregiver-reported health care provider recommendation of HPV vaccines among 13-to-17-year-old adolescents in the United States. Using a cross-sectional design to examine data from the National Immunization Survey–Teen (2023), multivariable logistic regression was used to model state-specific variations in provider recommendation of HPV vaccine. Proportion estimation was used to examine state-specific prevalence. Provider recommendation varied considerably across states. For example, the odds of reporting a recommendation were lower among caregivers of adolescents in Arkansas (adjusted odds ratio [AOR] = 0.56, 95
Purpose The proportion of women participating in the German mammography screening program (MSP) is only 50% from a cross-sectional perspective. We aimed to determine longitudinal participation over 11 years (from age 50 to 60). Methods We used cohort data with screening information from the cancer registry of North-Rhine Westphalia (NRW), covering the entire population of this federal state, and health claims data covering ~ 20% of the German population. We followed women born in 1959 from 2009 until 2019 and determined the proportion with ≥ 1 MSP participation. We repeated the analyses for other birth cohorts (1960–1962) and described participation patterns including age at first participation. Results The proportion with ≥ 1 MSP participation was ~ 70%. This was consistent across both data sources for the 1959 birth cohort (NRW: 75.4%; health claims data: 71.0%) and across birth cohorts (1960: 70.4%, 1961: 70.1%, 1962: 69.7%). Among participating women, ~ 90% were between age 50 and 53 at first participation; 52.4% did not participate regularly. Conclusion The proportion of women participating at least once in the MSP in 11 years is substantially higher compared to the proportion of invited women participating per year (cross-sectional perspective). Studies are required that explore reasons for irregular participation.
The proportion of women participating in the German mammography screening program (MSP) is only 50
This study aimed to investigate the association between body compositions with overall/subtype-specific HNC risks. We included participants from the UK Biobank with complete body composition data and without other cancers. Prospective analysis further excluded prevalent HNC. Multivariable logistic and Cox proportional hazards regression models were used to assess the associations. Subgroup analysis was stratified by age, sex, and smoking status. Among 399,640 participants included, 1,342 HNC cases were identified. Multiple body composition measures showed protective effects against overall HNC, including body mass index (BMI, overweight: odds ratio [OR] = 0.76, p < 0.001; obese: OR = 0.67, p < 0.001) and fat percentage of the whole-body (OR = 0.78, p < 0.001), trunk (OR = 0.81, p < 0.001), legs (OR = 0.74, p < 0.001), and arms (OR = 0.80, p < 0.001). Fat-free mass (FFM) of the whole-body (OR = 0.98, p < 0.001), trunk (OR = 0.95, p < 0.001), legs (OR = 0.88, p < 0.001) and arms (OR = 0.70, p < 0.001) also demonstrated protective effects. The majority of these associations were significant in young males and ever-smokers, and the effects of FFM remained significant in old males and females. Additionally, site-specific body composition factors showed complex relationships with HNC subtypes and the prospective analysis confirmed most observed associations. BMI, fat percentage, and FFM were associated with lower risk of overall HNC, functioning mainly in males and old females.
Colibactin-producing Escherichia coli (pks+ E. coli) has been linked to colorectal cancer (CRC) through double-strand DNA breaks and distinct mutational signatures. Whether gut colonization by pks+ E. coli is persistent and has direct implications for whether it represents a modifiable risk factor in diagnosed patients. Based on whole-genome metagenomic sequencing data from 638 individuals it was found that pks+ E. coli was significantly more prevalent in CRC patients (34.7